Author

Yuliia Dramaretska

Max Delbrück CenterORCID 0000-0002-9792-0465Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Ali Osman ÇetiniD· 1 shared Gaetano GargiuloiD· 1 shared Heike NaumanniD· 1 shared Jean‐Christophe MarineiD· 1 shared Jeroen DeclercqiD· 1 shared Lucas F. MacieliD· 1 shared Maria ZschummeliD· 1 shared Marie-Liesse Asselin-LabatiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ali Osman ÇetinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Transcriptional Dosage of Oncogenic KRAS Drives Lung Adenocarcinoma Cell States, Progression and Metastasis

Michela Serresi, Ali Osman Çetin, Yuliia Dramaretska, Sonia Kertalli, Matthias Jürgen Schmitt, Heike Naumann, Maria Zschummel, Marie-Liesse Asselin-Labat, Lucas F. Maciel, Jeroen Declercq, Jean‐Christophe Marine, Gaetano Gargiulo

This study shows that varying levels of oncogenic KRAS drive different cell states and metastatic progression in lung adenocarcinoma, with implications for treatment.

bioRxiv · Dec 29, 2024 · PreprintCancer Biology